miércoles, 14 de febrero de 2018

Press Announcements > FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

Press Announcements > FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients







Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients. Continue reading.

No hay comentarios: